Quantcast

Latest rheumatism Stories

2012-06-08 13:30:08

A new study presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, reinforces current thinking that smoking negatively affects treatment response in rheumatoid arthritis (RA) patients treated with anti-tumor necrosis factor (anti-TNF) drugs. This American study, the largest of its kind, followed 2,811 treatment naïve patients initiated onto anti-TNF therapy. Of the study group, 19% (n=521) were smokers and 81% (n=2,290) were non-smokers....

2012-06-08 11:04:44

Study results show these patients are 50% less likely to develop severe rheumatoid arthritis A new study presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, shows that early menopause predicts a milder form of rheumatoid arthritis (RA). New insights on factors influencing RA are good news for sufferers of the chronic inflammatory disease that currently affects over 2 million women in Europe. The study, based on 134 incident RA cases, found that...

2012-06-07 11:56:18

Results of a systematic review urge prophylactic treatment for those at risk Patients with inflammatory rheumatic diseases (IRD) treated with anti-tumor necrosis factor medications (anti-TNFs) have a 75% greater risk of developing herpes zoster, or shingles, than patients treated with traditional disease modifying anti-rheumatic drugs (DMARDs), according to a meta-analysis presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism. "Anti-TNFs, such as...

2012-06-07 11:50:32

Data presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, demonstrates that tailoring biologic treatment to individual patients with rheumatoid arthritis (RA) can reduce total costs by 2,595,557 per 272 patients over 3 years (95 percentile range -2,983,760 to -2,211,755), whilst increasing effectiveness by an average of 3.67 quality-adjusted life years (QALYs). Cost savings were mostly on drug costs. The Dutch study, which investigated 272 patients...

2012-06-06 12:30:57

Safety results were similar between groups Data presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, demonstrates that tocilizumab monotherapy is more effective than adalimumab monotherapy in the treatment of rheumatoid arthritis (RA) based on change from baseline in DAS28 (-3.3 vs. -1.8, p<0.0001) at week 24. The ADACTA trial, conducted in 325 patients with RA showed that tocilizumab was more effective than adalimumab for DAS28 remission (39.9%...

2012-06-06 12:28:10

Further data reveals there is no consistent criteria for biologic reimbursement in place Data from a study presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, demonstrates the vast inequalities in access to biologics for the treatments of rheumatoid arthritis (RA) across 46 European countries, with 22% (n=10) of countries having no biologic reimbursed at all. In the 36 countries with reimbursed biologics, only 27 had more than five biologics...

2012-06-01 08:59:44

Education is key to success; functional disability negatively impacts job performance As children with juvenile idiopathic arthritis (JIA) grow into adulthood, disability due to disease may adversely affect their ability to achieve educational success. Findings published in Arthritis & Rheumatism, a journal of the American College of Rheumatology (ACR), suggest that functional disability impacts educational attainment, which is key to successful employment in adulthood. Arthritis is...

2012-05-17 23:04:58

The Rheumatology and Surgery Sciences are two new key health categories covered by the Sciences Social Network. The users of the website monitor 184 scientific journals and submit the most significant scientific results of these journals for inclusion in these two categories which currently contain a total of 39,522 articles. Science Index was established in 1998 to index the very latest news, headlines, references and resources in all fields of biology, business, chemistry, engineering,...

Advisory Panel Recommends FDA Approval Of Rheumatoid Arthritis Drug
2012-05-11 05:46:04

Connie K. Ho for RedOrbit.com An advisory panel recommends that the U.S. Food and Drug Administration (FDA) consider approving Pfizer´s pill to treat rheumatoid arthritis. The pill, tofacitinib, would be sold to patients who don´t respond to traditional rheumatoid arthritis treatments. On May 9, the panel of outside experts voted 8-2 to recommend the drug for approval. However, the agency doesn´t necessarily need to follow the panel´s advice. Tofacitinib is one of...


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related